Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
British Journal of Cancer
|
March 1, 1988
In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil
G J Peters, J van Dijk, E Laurensse, et al.
Cancer Research
|
August 1, 1990
In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients
G J Peters, G Schwartsmann, J C Nadal, et al.
Journal of Cellular Biochemistry
|
August 1, 1989
Purification and partial characterization of a hepatocyte antiproliferative glycopeptide
G Auger, D Blanot, J van Heijenoort, et al.
HIV Medicine
|
June 4, 2009
Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease
A Imaz, V Falcó, M Peñaranda, et al.
Actas Dermo-Sifiliograficas
|
March 7, 2019
Spanish Consensus Document on the Treatment Algorithm for Rosacea
M Salleras, M Alegre, V Alonso-Usero, et al.
Scientific Reports
|
February 24, 2019
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2026
Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano, et al.
Scientific Reports
|
May 18, 2019
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
British Journal of Cancer
|
March 1, 1988
In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil
G J Peters, J van Dijk, E Laurensse, et al.
Cancer Research
|
August 1, 1990
In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients
G J Peters, G Schwartsmann, J C Nadal, et al.
Journal of Cellular Biochemistry
|
August 1, 1989
Purification and partial characterization of a hepatocyte antiproliferative glycopeptide
G Auger, D Blanot, J van Heijenoort, et al.
HIV Medicine
|
June 4, 2009
Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease
A Imaz, V Falcó, M Peñaranda, et al.
Actas Dermo-Sifiliograficas
|
March 7, 2019
Spanish Consensus Document on the Treatment Algorithm for Rosacea
M Salleras, M Alegre, V Alonso-Usero, et al.
Scientific Reports
|
February 24, 2019
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2026
Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano, et al.
Scientific Reports
|
May 18, 2019
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano, et al.
Page
of 8